Business

DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative

NEW YORK and CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital

articleDariohealth Corp.August 15, 20195/company/dariohealth-corp/news/dariohealth-announces-alliance-with-digitalhealthlondon-as-part-of-the-uk-israel-dangoor-health-initiative
DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative

About this update from Dariohealth Corp.

[{"type":"text","content":"NEW YORK and CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- DarioHealth Corp. (\"DarioHealth\" or \"Dario\") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (\"DH.L\") as part of its UK Israel Dangoor Health Initiative (the \"Initiative\"), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients.\n\n \nDario was selected by DH.L to help bring its highly regarded digital therapeutics technology to assist NHS patients in better managing their chronic health conditions, such as pre-diabetes, diabetes and hypertension, among other chronic conditions. \nThe Initiative is a partnership between the UK Israel Tech Hub, which aims to help British companies partner with cutting-edge technology companies in Israel; DigitalHealth.London, a collaborative that helps high-potential, digital health start-up companies connect with the NHS; and Dangoor Education.\nDH.L is well placed to accelerate the adoption and scaling of digital innovations across the NHS. The Initiative will help facilitate additional access for DarioHealth to key UK clinicians, academic institutes, healthcare system experts and industries in order to better understand the needs of patients and the NHS.\n\"With 25 per cent of middle-aged adults suffering from hypertension and 2.6 million people diagnosed with diabetes, the NHS needs the very best in digital innovation in order to manage chronic disease conditions successfully, now and into the future,\" said Dror Bacher, Chief Operating Officer at DarioHealth Corp. \"I recently had the pleasure of meeting key NHS clinicians and influencers and learned first-hand about the challenges and opportunities that they're experiencing within the healthcare sector. DarioHealth is well positioned to offer quality digital therapeutic interventions for managing chronic conditions and looks forward to exploring opportunities for integration and partnership with both primary and secondary care providers. Through our collaboration, we will examine the best ways to develop new Dario digital therapeutic solutions for people with chronic conditions within the framework of the NHS.\" \nA key differentiator of Dario's performance-based platform is its emphasis on behavioral engagement with users, through the...

More updates from Dariohealth Corp.